Evaluation of a Collagen-Chitosan Hydrogel for Potential Use as a Pro-Angiogenic Site for Islet Transplantation

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  McBane, Joanne E ^a,b   Vulesevic, Branka ^a,b   Padavan, Donna T ^a   McEwan, Kimberly A ^a,b   Korbutt, Gregory S ^c   Suuronen, Erik J ^a,b  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MARKER; CHEMOKINE RECEPTOR CXCR4; CHITOSAN; COLLAGEN; COLLAGENASE; CYTOKINE; CYTOKINE ANTIBODY; VASCULAR CELL ADHESION MOLECULE 1;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL COUNT; CELL TYPE; CELL VIABILITY; CIRCULATING ANGIOGENIC CELL; CONTROLLED STUDY; CROSS LINKING; CYTOKINE RESPONSE; DEGRADATION; GELATION; HUMAN; HUMAN CELL; HYDROGEL; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MOUSE; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PROTEIN EXPRESSION; STREPTOZOCIN DIABETES; YOUNG MODULUS;

ANGIOGENIC PROTEINS; ANIMALS; CELL SURVIVAL; CELLS, CULTURED; CHITOSAN; COLLAGEN; CYTOKINES; DIABETES MELLITUS, TYPE 1; HUMANS; HYDROGEL; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; MICE; RATS;

EID: 84885740955     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0077538     Document Type: Article

References (46)

1. Shapiro AM, Ricordi C, Hering BJ, Auchincloss H, Lindblad R, et al. (2006) International trial of the Edmonton protocol for islet transplantation. N Engl J Med 355: 1318-1330. doi:10.1056/NEJMoa061267. PubMed: 17005949.
2. Ryan EA, Paty BW, Senior PA, Bigam D, Alfadhli E, et al. (2005) Five-year follow-up after clinical islet transplantation. Diabetes 54: 2060-2069. doi:10.2337/diabetes.54.7.2060. PubMed: 15983207.
3. Merani S, Toso C, Emamaullee J, Shapiro AM, (2008) Optimal implantation site for pancreatic islet transplantation. Br J Surg 95: 1449-1461. doi:10.1002/bjs.6391. PubMed: 18991254.
4. Carlsson PO, (2010) Influence of microenvironment on engraftment of transplanted beta-cells. Ups J Med Sci 116: 1-7.
5. Ishiyama K, Rawson J, Omori K, Mullen Y, (2011) Liver natural killer cells play a role in the destruction of islets after intraportal transplantation. Transplantation 91: 952-960. doi:10.1097/TP.0b013e3182139dc1. PubMed: 21389902.
6. Jacobs-Tulleneers-Thevissen D, Bartholomeus K, Suenens K, Vermeulen I, Ling Z, et al. (2010) Human islet cell implants in a nude rat model of diabetes survive better in omentum than in liver with a positive influence of beta cell number and purity. Diabetologia 53: 1690-1699. doi:10.1007/s00125-010-1721-0. PubMed: 20397000.
7. Forster NA, Penington AJ, Hardikar AA, Palmer JA, Hussey A, et al. (2011) A prevascularized tissue engineering chamber supports growth and function of islets and progenitor cells in diabetic mice. Islets 3: 271-283. doi:10.4161/isl.3.5.15942. PubMed: 21847009.
8. Kaufman-Francis K, Koffler J, Weinberg N, Dor Y, Levenberg S, (2012) Engineered vascular beds provide key signals to pancreatic hormone-producing cells. PLOS ONE 7: e40741. doi:10.1371/journal.pone.0040741. PubMed: 22808248.
9. Bowers DT, Chhabra P, Langman L, Botchwey EA, Brayman KL, (2011) FTY720-loaded poly(DL-lactide-co-glycolide) electrospun scaffold significantly increases microvessel density over 7 days in streptozotocin-induced diabetic C57b16/J mice: preliminary results. Transplant Proc 43: 3285-3287. doi:10.1016/j.transproceed.2011.09.008. PubMed: 22099778.
10. Kim JS, Lim JH, Nam HY, Lim HJ, Shin JS, et al. (2012) In situ application of hydrogel-type fibrin-islet composite optimized for rapid glycemic control by subcutaneous xenogeneic porcine islet transplantation. J Control Release 162: 382-390. doi:10.1016/j.jconrel.2012.07.018. PubMed: 22820449.
11. Kriz J, Vilk G, Mazzuca DM, Toleikis PM, Foster PJ, et al. (2012) A novel technique for the transplantation of pancreatic islets within a vascularized device into the greater omentum to achieve insulin independence. Am J Surg 203: 793-797. doi:10.1016/j.amjsurg.2011.02.009. PubMed: 21683938.
12. Kakabadze Z, Gupta S, Brandhorst D, Korsgren O, Berishvili E, (2011) Long-term engraftment and function of transplanted pancreatic islets in vascularized segments of small intestine. Transpl Int 24: 175-183. doi:10.1111/j.1432-2277.2010.01160.x. PubMed: 20819197.
13. Eizirik DL, Colli ML, Ortis F, (2009) The role of inflammation in insulitis and beta-cell loss in type 1 diabetes. Nat Rev Endocrinol 5: 219-226. doi:10.1038/nrendo.2009.21. PubMed: 19352320.
14. Deng C, Zhang P, Vulesevic B, Kuraitis D, Li F, et al. (2010) A Collagen-Chitosan Hydrogel for Endothelial Differentiation and Angiogenesis. Tissue Eng A 16: 3099-3109. doi:10.1089/ten.tea.2009.0504.
15. Kuraitis D, Hou C, Zhang Y, Vulesevic B, Sofrenovic T, et al. (2011) Ex vivo generation of a highly potent population of circulating angiogenic cells using a collagen matrix. J Mol Cell Cardiol 51: 187-197. doi:10.1016/j.yjmcc.2011.04.011. PubMed: 21569777.
16. Pan SK, Wu SJ, Kim JM, (2011) Preparation of glucosamine by hydrolysis of chitosan with commercial alpha-amylase and glucoamylase. J Zhejiang Univ Sci B 12: 931-934. doi:10.1631/jzus.B1100065. PubMed: 22042658.
17. McEwan K, Padavan DT, Deng C, Vulesevic B, Kuraitis D, et al. (2012) Tunable collagen hydrogels are modified by the therapeutic agents they are designed to deliver. J Biomater Sci Polym Ed 23: pp. 1467-1483. PubMed: 21771391.
18. Paik SG, Fleischer N, Shin SI, (1980) Insulin-dependent diabetes mellitus induced by subdiabetogenic doses of streptozotocin: obligatory role of cell-mediated autoimmune processes. Proc Natl Acad Sci U S A 77: 6129-6133. doi:10.1073/pnas.77.10.6129. PubMed: 6449703.
19. Deng C, Vulesevic B, Ellis C, Korbutt GS, Suuronen EJ, (2011) Vascularization of collagen-chitosan scaffolds with circulating progenitor cells as potential site for islet transplantation. J Control Release 152 (Suppl 1):: e196-e198. doi:10.1016/j.jconrel.2011.09.005. PubMed: 22195848.
20. Yeung TY, Seeberger KL, Kin T, Adesida A, Jomha N, et al. (2012) Human mesenchymal stem cells protect human islets from pro-inflammatory cytokines. PLOS ONE 7: e38189. doi:10.1371/journal.pone.0038189. PubMed: 22666480.
21. Mandrup-Poulsen T, Helqvist S, Wogensen LD, Mølvig J, Pociot F, et al. (1990) Cytokine and free radicals as effector molecules in the destruction of pancreatic beta cells. Curr Top Microbiol Immunol 164: 169-193. doi:10.1007/978-3-642-75741-9_9. PubMed: 2073784.
22. Cardozo AK, Proost P, Gysemans C, Chen MC, Mathieu C, et al. (2003) IL-1beta and IFN-gamma induce the expression of diverse chemokines and IL-15 in human and rat pancreatic islet cells, and in islets from pre-diabetic NOD mice. Diabetologia 46: 255-266. PubMed: 12627325.
23. Yamada K, Otabe S, Inada C, Takane N, Nonaka K, (1993) Nitric oxide and nitric oxide synthase mRNA induction in mouse islet cells by interferon-gamma plus tumor necrosis factor-alpha. Biochem Biophys Res Commun 197: 22-27. doi:10.1006/bbrc.1993.2435. PubMed: 7504484.
24. Rafael E, Wu GS, Hultenby K, Tibell A, Wernerson A, (2003) Improved survival of macroencapsulated islets of Langerhans by preimplantation of the immunoisolating device: a morphometric study. Cell Transplant 12: 407-412. PubMed: 12911128.
25. Witkowski P, Sondermeijer H, Hardy MA, Woodland DC, Lee K, et al. (2009) Islet grafting and imaging in a bioengineered intramuscular space. Transplantation 88: 1065-1074. doi:10.1097/TP.0b013e3181ba2e87. PubMed: 19898201.
26. Kriz J, Jirak D, Vilk GJ, Girman P, White DJ, et al. (2010) Vascularization of artificial beds for pancreatic islet transplantation in a rat model. Transplant Proc 42: 2097-2101. doi:10.1016/j.transproceed.2010.05.088. PubMed: 20692417.
27. Sörenby AK, Kumagai-Braesch M, Sharma A, Hultenby KR, Wernerson AM, et al. (2008) Preimplantation of an immunoprotective device can lower the curative dose of islets to that of free islet transplantation: studies in a rodent model. Transplantation 86: 364-366. doi:10.1097/01.tp.0000331700.75696.61. PubMed: 18645504.
28. Pileggi A, Molano RD, Ricordi C, Zahr E, Collins J, et al. (2006) Reversal of diabetes by pancreatic islet transplantation into a subcutaneous, neovascularized device. Transplantation 81: 1318-1324. doi:10.1097/01.tp.0000203858.41105.88. PubMed: 16699461.
29. Balamurugan AN, Gu Y, Tabata Y, Miyamoto M, Cui W, et al. (2003) Bioartificial pancreas transplantation at prevascularized intermuscular space: effect of angiogenesis induction on islet survival. Pancreas 26: 279-285. doi:10.1097/00006676-200304000-00012. PubMed: 12657955.
30. Dong L, Kang L, Ding L, Chen Q, Bai J, et al. (2011) Insulin modulates ischemia-induced endothelial progenitor cell mobilization and neovascularization in diabetic mice. Microvasc Res 82: 227-236. doi:10.1016/j.mvr.2011.09.006. PubMed: 21964072.
31. Moore WV, Bieser K, Geng Z, Tong PY, Kover K, (2002) Decreased survival of islet allografts in rats with advanced chronic complications of diabetes. Cell Transplant 11: 707-713. PubMed: 12518897.
32. Deng C, Li F, Griffith M, Ruel M, Suuronen EJ, (2010) Application of Chitosan-Based Biomaterials for Blood Vessel Regeneration. Macromol Symp 297: 138-146. doi:10.1002/masy.200900149.
33. Abaci A, Oǧuzhan A, Kahraman S, Eryol NK, Unal S, et al. (1999) Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation 99: 2239-2242. doi:10.1161/01.CIR.99.17.2239. PubMed: 10226087.
34. Gallagher KA, Liu ZJ, Xiao M, Chen H, Goldstein LJ, et al. (2007) Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha. J Clin Invest 117: 1249-1259. doi:10.1172/JCI29710. PubMed: 17476357.
35. Takahashi T, Kalka C, Masuda H, Chen D, Silver M, et al. (1999) Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 5: 434-438. doi:10.1038/7434. PubMed: 10202935.
36. Chavakis E, Aicher A, Heeschen C, Sasaki K, Kaiser R, et al. (2005) Role of beta2-integrins for homing and neovascularization capacity of endothelial progenitor cells. J Exp Med 201: 63-72. doi:10.1084/jem.20041402. PubMed: 15623573.
37. Loomans CJ, de Koning EJ, Staal FJ, Rookmaaker MB, Verseyden C, et al. (2004) Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes 53: 195-199. doi:10.2337/diabetes.53.1.195. PubMed: 14693715.
38. Fadini GP, Agostini C, Avogaro A, (2005) Endothelial progenitor cells and vascular biology in diabetes mellitus: current knowledge and future perspectives. Curr. Diabetes Rev 1: 41-58. doi:10.2174/1573399052952640.
39. Albiero M, Fadini GP, (2012) Strategies for enhancing progenitor cell mobilization and function in diabetes. Curr Vasc Pharmacol 10: 310-321. doi:10.2174/157016112799959387. PubMed: 22239633.
40. Trichet L, Le Digabel J, Hawkins RJ, Vedula SR, Gupta M, et al. (2012) Evidence of a large-scale mechanosensing mechanism for cellular adaptation to substrate stiffness. Proc Natl Acad Sci U S A 109: 6933-6938. doi:10.1073/pnas.1117810109. PubMed: 22509005.
41. Engler AJ, Sen S, Sweeney HL, Discher DE, (2006) Matrix elasticity directs stem cell lineage specification. Cell 126: 677-689. doi:10.1016/j.cell.2006.06.044. PubMed: 16923388.
42. Stamenović D, Wang N, (2000) Invited review: engineering approaches to cytoskeletal mechanics. J Appl Physiol 89: 2085-2090. PubMed: 11053366.
43. Annabi N, Nichol JW, Zhong X, Ji C, Koshy S, et al. (2010) Controlling the porosity and microarchitecture of hydrogels for tissue engineering. Tissue Eng B Rev 16: 371-383. doi:10.1089/ten.teb.2009.0639. PubMed: 20121414.
44. Weber LM, Lopez CG, Anseth KS, (2009) Effects of PEG hydrogel crosslinking density on protein diffusion and encapsulated islet survival and function. J Biomed Mater Res A 90: 720-729. PubMed: 18570315.
45. Lin CC, Raza A, Shih H, (2011) PEG hydrogels formed by thiol-ene photo-click chemistry and their effect on the formation and recovery of insulin-secreting cell spheroids. Biomaterials 32: 9685-9695. doi:10.1016/j.biomaterials.2011.08.083. PubMed: 21924490.
46. Muthyala S, Bhonde RR, Nair PD, (2010) Cytocompatibility studies of mouse pancreatic islets on gelatin--PVP semi IPN scaffolds in vitro: potential implication towards pancreatic tissue engineering. Islets 2: 357-366. doi:10.4161/isl.2.6.13765. PubMed: 21157182.